Matthew is interested in computational modelling of gene regulatory networks in cancer, particularly in breast cancer and glioblastoma (GBM). His work focuses on the DNA damage response (DDR) pathway.
June 15, 2020
Matthew is interested in computational modelling of gene regulatory networks in cancer, particularly in breast cancer and glioblastoma (GBM). His work focuses on the DNA damage response (DDR) pathway.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
